Ampersand is a Massachusetts-based biotechnology platform that researches and develops programmable drugs to precisely treat the affected body part.
$65M
Mar 18, 2025
-
Maxion Therapeutics is an England-based biotechnology company that researches and develops protein therapeutics for the treatment of cancer and diabetes.
$72M
Mar 16, 2025
-
Orbis is a Denmark-based drug discovery platform that researches and develops oral macrocycle biologic drugs for the treatment of various diseases.
$92.8M
Jan 05, 2025
-
$4M
Nov 17, 2024
-
TRexBio is a California-based biotechnology company that researches and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases.
$84M
Nov 12, 2024
-
Frequently Asked Questions about Lilly
What is Lilly investing in?
Lilly has invested in 104 companies including Ampersand, Maxion Therapeutics and Orbis
What company did Lilly invest in?
Lilly invested in a total 104 companies including Ampersand, Maxion Therapeutics and Orbis
What are the top 5 investments by Lilly?
The top companies in which Lilly invested are Ampersand, Maxion Therapeutics, Orbis, Revisto and TRex Bio
